Date | Time | Source | Headline | Symbol | Company |
04/08/2015 | 2:27PM | Business Wire | Keller Rohrback L.L.P. Announces Investigation Regarding Weight-Loss & Workout Supplements Containing Potentially Dangerous A... | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/28/2014 | 1:39PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/21/2014 | 12:18PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 1:13PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 1:10PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 1:07PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 12:57PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 12:41PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 10:27AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 9:20AM | Business Wire | Akorn Completes Acquisition of Hi-Tech Pharmacal | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/17/2014 | 9:06AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/15/2014 | 5:53PM | PR Newswire (US) | Repligen Corporation Set to Join the S&P SmallCap 600 | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
04/14/2014 | 7:00PM | Business Wire | Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
03/21/2014 | 4:46PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
03/20/2014 | 2:44PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
03/13/2014 | 4:22PM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
03/12/2014 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
03/11/2014 | 11:25AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
03/11/2014 | 7:00AM | Business Wire | Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014 | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
03/10/2014 | 10:59AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
02/12/2014 | 6:01AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
02/11/2014 | 6:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
02/07/2014 | 12:59PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
01/31/2014 | 9:36AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
01/23/2014 | 7:00AM | Business Wire | Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day) | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
12/26/2013 | 7:00AM | Business Wire | Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
12/10/2013 | 7:00AM | Business Wire | Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013 | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
11/15/2013 | 7:11AM | Dow Jones News | AQR Capital Management 3Q 13F: Largest Purchases -2- | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
11/15/2013 | 7:11AM | Dow Jones News | AQR Capital Management 3Q 13F: Largest Purchases | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |
11/15/2013 | 7:11AM | Dow Jones News | AQR Capital Management 3Q 13F: Holdings As Of Sep -2- | NASDAQ:HITK | Hi-Tech Pharmacal Co., Inc. (MM) |